Alexander Introduces Pharmaceutical Compounding Legislation

Wednesday, May 15, 2013

Chairman of the Senate Health, Education, Labor and Pensions Committee Senator Tom Harkin (D-Iowa) and Ranking Member Lamar Alexander (R-Tn.), with Senators Pat Roberts (R-Ks.) and Al Franken (D-Mn.) and other members of the HELP Committee, on Wednesday introduced legislation—the Pharmaceutical Compounding Quality and Accountability Act—that would improve the safety of compounded human and animal drugs by making clear the compounding oversight responsibilities of state and federal authorities. 

Chairman Harkin and Ranking Member Alexander also announced that the Committee will convene for an executive session next Wednesday, to consider the compounding bill, along with newly-introduced legislation to strengthen and improve the drug distribution supply chain.

In April, Senators Harkin, Alexander, Roberts, and Franken released draft legislation relating to pharmaceutical compounding and requested that stakeholders provide feedback on the policy merits, potential unintended consequences, and opportunities to improve the legislative language. Additionally, the HELP Committee held a legislative hearing in early May to listen to more in-depth testimonies from experts and stakeholders to improve the draft bill.  An updated one-pager, section-by-section and the Pharmaceutical Compounding Quality and Accountability Act can be viewed on the HELP Committee website.

The Pharmaceutical Compounding Quality and Accountability Act makes a clear distinction between traditional compounding—which will continue to be regulated primarily by state pharmacy boards—and compounding manufacturers that make sterile products without, or in advance of, a prescription and sell those products across state lines. The compounding manufacturers would be regulated by the U.S. Food and Drug Administration (FDA). It clarifies a national, uniform set of rules for compounding manufacturers while preserving the states’ primary role in traditional pharmacy regulation.

“We cannot wait for the next public health crisis—as we saw with the New England Compounding Company disaster that led to more than 50 deaths and caused serious illness in 700 more—to act to improve the safety of compounded drugs,” Chairman Harkin said. “The Pharmaceutical Compounding Quality and Accountability Act will help protect the public from unsafe compounded products and clarify FDA authority over high-risk compounding practices. I am proud of the bipartisan effort that members of this Committee have put forth in drafting this bill, and I am appreciative of the helpful and constructive feedback received from stakeholders throughout this process. I look forward to considering this bill in an executive session of the Committee next week.”

Senator Alexander said, “My primary goal with this legislation is to erase the confusion over who regulates pharmacies and manufacturing facilities, and make it clear exactly who oversees each business. Putting one agency on the flagpole for each of these businesses will mean greater safety for American families, so they don’t have to question whether the drugs they take are safe.”

“I am proud of the work we have done to craft a solution that protects patients, while preserving the practice of traditional pharmacy compounding,” Senator Roberts said. “After reviewing stakeholder comments, we made a concerted effort to address their concerns in this legislation. This bipartisan bill is balanced, clear and will leave no questions about the regulatory oversight of compounded drugs. I urge my colleagues to support it.”

"We've seen far too many deaths in Minnesota, and nationwide, because some pharmacies in this country have acted more like drug manufacturers – without following rigorous safety rules that drug manufacturers must follow,” said Senator Franken. “This bipartisan legislation will keep Minnesotans safe by ensuring that drug manufacturers have appropriate oversight, and that responsible pharmacies don't see any unnecessary restrictions."

In addition to distinguishing between pharmacies and manufacturers, and clarifying proper oversight of each, the legislation sets forth requirements on compounding manufacturers. Compounding manufacturers must register with the FDA and tell the agency what products they have made; make products under a pharmacist’s oversight and in compliance with good manufacturing practices; and investigate and report when things go wrong.

The bill allows FDA to identify categories of drugs that currently cannot be safely compounded; preserves and enhances current protections regarding the ingredients from which drugs are compounded; and preserves the line between compounding manufacturers and traditional manufacturers by placing prohibitions on wholesale distribution of compounded products.

The legislation also encourages communication among states and increases communication between states and the FDA. FDA will designate a point of contact for a State Board of Pharmacy to notify the agency if it appears that a state-licensed business should be registered as a compounding pharmacy. The FDA must notify the state within 15 days if it determines that business is a compounding manufacturer.

Professional Park Associates In LaFayette Hosts Drive-Thru Flu Vaccine Clinics

Professional Park Associates in LaFayette will host its 3rd annual drive-thru flu vaccine clinics in October.   A  Saturday  clinic has been added this year to help meet the needs of the community.  Three weekday clinics, as well as two evening clinics, will also be offered.   Regular flu vaccines will be available for ages 4 and up. Those ... (click for more)

BlueCross Picks Director Of Health And Wellness Product Strategy

BlueCross BlueShield of Tennessee has selected Tina Mathur as director of health and wellness product strategy. In this role, Ms. Mathur will lead the BlueHealth Solutions team, which produces and manages workplace wellness programs and health management initiatives for large BlueCross-insured employers. “We are excited to have Tina as part of our leadership team,” said ... (click for more)

Attorney Patrick Says Chattanooga Is "Most Logical Place" For Consolidating Volkswagen Lawsuits; Hearing Set Dec. 3

Attorney Gary Patrick said Chattanooga is "the most logical place for consolidating the Volkswagen litigation because it is the only location in the country where VW vehicles are being produced." Attorney Patrick, of the local firm of Patrick, Beard, Schulman and Jacoway, said a hearing is set Dec. 3 in New Orleans on the issue. A host of lawsuits seeking class action status ... (click for more)

Woman Stabbed To Death On Hooker Road; Man Injured; Suspect Being Interviewed

A young woman was stabbed to death on Hooker Road early Friday morning and a man was injured. At approximately 1:54 a.m., Chattanooga Police responded to a stabbing at the 4000 block of Hooker Road. There police located Angel Evans, 33, deceased. She was stabbed multiple times. A second person, Gerald Nelson, 24, was transported to a local hospital with non-life-threatening ... (click for more)

The Facts About Jail

Since Roy had such a positive reaction to Jeffrey Cross's wonderful (and wonderfully civil--how refreshing) email response to his column on the bike lanes, allow me to speak on the subject of the jail.  First off, Roy's right about some things:  It is overcrowded, underfunded, and understaffed.  This is no secret, it's in the Grand Jury report every term.  Here's ... (click for more)

Roy Exum: We Must Learn To Tell

On July 4th of this year, FBI agents – acting on a tip -- arrested Alexander Ciccolo, a 23-year-old with known mental problems, as he carried a duffle bag full of automatic attack weapons. Moments before, he had bought the illegal firearms from an undercover informant outside of Boston. As agents later scoured his apartment, they found bomb-making equipment including a pressure ... (click for more)